vs

Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

CBAK Energy Technology, Inc. is the larger business by last-quarter revenue ($58.8M vs $41.8M, roughly 1.4× Neuronetics, Inc.). CBAK Energy Technology, Inc. runs the higher net margin — -12.5% vs -17.2%, a 4.7% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs 85.7%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs -0.0%).

CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

CBAT vs STIM — Head-to-Head

Bigger by revenue
CBAT
CBAT
1.4× larger
CBAT
$58.8M
$41.8M
STIM
Growing faster (revenue YoY)
CBAT
CBAT
+46.0% gap
CBAT
131.8%
85.7%
STIM
Higher net margin
CBAT
CBAT
4.7% more per $
CBAT
-12.5%
-17.2%
STIM
More free cash flow
CBAT
CBAT
$15.4M more FCF
CBAT
$16.1M
$692.0K
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
-0.0%
CBAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBAT
CBAT
STIM
STIM
Revenue
$58.8M
$41.8M
Net Profit
$-7.4M
$-7.2M
Gross Margin
7.3%
52.0%
Operating Margin
-13.6%
-12.1%
Net Margin
-12.5%
-17.2%
Revenue YoY
131.8%
85.7%
Net Profit YoY
-63.6%
43.2%
EPS (diluted)
$-0.08
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBAT
CBAT
STIM
STIM
Q4 25
$58.8M
$41.8M
Q3 25
$60.9M
$37.3M
Q2 25
$40.5M
$38.1M
Q1 25
$34.9M
$32.0M
Q4 24
$25.4M
$22.5M
Q3 24
$44.6M
$18.5M
Q2 24
$47.8M
$16.4M
Q1 24
$58.8M
$17.4M
Net Profit
CBAT
CBAT
STIM
STIM
Q4 25
$-7.4M
$-7.2M
Q3 25
$2.7M
$-9.0M
Q2 25
$-3.1M
$-10.1M
Q1 25
$-1.6M
$-12.7M
Q4 24
$-4.5M
$-12.7M
Q3 24
$17.6K
$-13.3M
Q2 24
$6.4M
$-9.8M
Q1 24
$9.8M
$-7.9M
Gross Margin
CBAT
CBAT
STIM
STIM
Q4 25
7.3%
52.0%
Q3 25
8.0%
45.9%
Q2 25
11.0%
46.6%
Q1 25
13.7%
49.2%
Q4 24
13.1%
66.2%
Q3 24
15.6%
75.6%
Q2 24
26.6%
74.0%
Q1 24
31.9%
75.1%
Operating Margin
CBAT
CBAT
STIM
STIM
Q4 25
-13.6%
-12.1%
Q3 25
-6.6%
-19.6%
Q2 25
-8.7%
-21.1%
Q1 25
-8.2%
-34.4%
Q4 24
-26.0%
-51.0%
Q3 24
-1.9%
-41.7%
Q2 24
12.4%
-51.7%
Q1 24
17.4%
-39.4%
Net Margin
CBAT
CBAT
STIM
STIM
Q4 25
-12.5%
-17.2%
Q3 25
4.4%
-24.3%
Q2 25
-7.6%
-26.6%
Q1 25
-4.5%
-39.6%
Q4 24
-17.8%
-56.4%
Q3 24
0.0%
-72.0%
Q2 24
13.5%
-59.8%
Q1 24
16.7%
-45.2%
EPS (diluted)
CBAT
CBAT
STIM
STIM
Q4 25
$-0.08
$-0.10
Q3 25
$0.03
$-0.13
Q2 25
$-0.03
$-0.15
Q1 25
$-0.02
$-0.21
Q4 24
$-0.05
$-0.34
Q3 24
$0.00
$-0.44
Q2 24
$0.07
$-0.33
Q1 24
$0.11
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBAT
CBAT
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$8.3M
$28.1M
Total DebtLower is stronger
$4.1M
$65.8M
Stockholders' EquityBook value
$112.7M
$22.4M
Total Assets
$426.2M
$141.6M
Debt / EquityLower = less leverage
0.04×
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBAT
CBAT
STIM
STIM
Q4 25
$8.3M
$28.1M
Q3 25
$10.5M
$28.0M
Q2 25
$45.7M
$11.0M
Q1 25
$9.6M
$20.2M
Q4 24
$11.0M
$18.5M
Q3 24
$24.2M
$20.9M
Q2 24
$44.1M
$42.6M
Q1 24
$23.8M
$47.7M
Total Debt
CBAT
CBAT
STIM
STIM
Q4 25
$4.1M
$65.8M
Q3 25
$4.8M
$65.7M
Q2 25
$4.9M
$55.5M
Q1 25
$4.1M
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Q1 24
$59.4M
Stockholders' Equity
CBAT
CBAT
STIM
STIM
Q4 25
$112.7M
$22.4M
Q3 25
$121.4M
$27.4M
Q2 25
$118.2M
$27.1M
Q1 25
$120.8M
$35.5M
Q4 24
$121.7M
$27.7M
Q3 24
$131.2M
$9.4M
Q2 24
$126.6M
$19.4M
Q1 24
$120.9M
$27.7M
Total Assets
CBAT
CBAT
STIM
STIM
Q4 25
$426.2M
$141.6M
Q3 25
$363.9M
$145.5M
Q2 25
$333.1M
$134.7M
Q1 25
$311.5M
$142.0M
Q4 24
$302.2M
$140.9M
Q3 24
$293.5M
Q2 24
$279.6M
$96.8M
Q1 24
$286.5M
$103.8M
Debt / Equity
CBAT
CBAT
STIM
STIM
Q4 25
0.04×
2.94×
Q3 25
0.04×
2.40×
Q2 25
0.04×
2.05×
Q1 25
0.03×
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBAT
CBAT
STIM
STIM
Operating Cash FlowLast quarter
$29.8M
$908.0K
Free Cash FlowOCF − Capex
$16.1M
$692.0K
FCF MarginFCF / Revenue
27.3%
1.7%
Capex IntensityCapex / Revenue
23.4%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$3.9M
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBAT
CBAT
STIM
STIM
Q4 25
$29.8M
$908.0K
Q3 25
$14.6M
$-785.0K
Q2 25
$13.8M
$-3.5M
Q1 25
$-9.6M
$-17.0M
Q4 24
$9.6M
$-8.6M
Q3 24
$19.7M
$-5.4M
Q2 24
$2.9M
$-5.0M
Q1 24
$7.4M
$-12.0M
Free Cash Flow
CBAT
CBAT
STIM
STIM
Q4 25
$16.1M
$692.0K
Q3 25
$6.0M
$-899.0K
Q2 25
$4.1M
$-3.8M
Q1 25
$-22.3M
$-17.2M
Q4 24
$3.9M
$-8.7M
Q3 24
$16.5M
$-5.8M
Q2 24
$2.5M
$-5.6M
Q1 24
$-454.0K
$-12.4M
FCF Margin
CBAT
CBAT
STIM
STIM
Q4 25
27.3%
1.7%
Q3 25
9.9%
-2.4%
Q2 25
10.2%
-9.9%
Q1 25
-63.9%
-53.8%
Q4 24
15.5%
-38.6%
Q3 24
37.1%
-31.3%
Q2 24
5.2%
-34.0%
Q1 24
-0.8%
-71.1%
Capex Intensity
CBAT
CBAT
STIM
STIM
Q4 25
23.4%
0.5%
Q3 25
14.1%
0.3%
Q2 25
23.8%
0.7%
Q1 25
36.3%
0.7%
Q4 24
22.5%
0.4%
Q3 24
7.0%
2.1%
Q2 24
0.9%
3.7%
Q1 24
13.4%
2.2%
Cash Conversion
CBAT
CBAT
STIM
STIM
Q4 25
Q3 25
5.51×
Q2 25
Q1 25
Q4 24
Q3 24
1115.72×
Q2 24
0.46×
Q1 24
0.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBAT
CBAT

Manufacturing Lithium Batteries$28.0M48%
Residential Energy Supply And Uninterruptable Supplies$17.8M30%
Light Electric Vehicles$12.9M22%
Precursor$108.0K0%

STIM
STIM

Segment breakdown not available.

Related Comparisons